KPT-330_1393477-72-9_DataSheet_MedChemExpress

合集下载

聚二甲基硅氧烷msds英文版

聚二甲基硅氧烷msds英文版以下是聚二甲基硅氧烷的MSDS（英文版）：Material Safety Data Sheet (MSDS)Product Na PolydimethylsiloxaneSection 1: Product and Company IdentificationProduct Na PolydimethylsiloxaneSynonyms: PDMS, Dimethicone, Silicone oilCAS No.: 63148-62-9Molecular Formula: (C2H6OSi)nManufacturer/Supplier: Beijing Haining Technology Co., LtdAddress: Room 101, Building A, No. 18 Shangdi Information Road, Haidian District, Beijing, ChinaTel: +86-10-12345678Fax: +86-10-12345678Email: info@hainingtechXXXSection 2: Composition/Information on IngredientsPolydimethylsiloxane is a polymer composed of repeating units of dimethylsiloxane. The molecular weight can vary from less than 1000 to more than 1 million. The following information pertains to a typical product with a molecular weight range of 10,000-100,000.Chemical Na PolydimethylsiloxaneCAS No.: 63148-62-9Molecular Weight: 10,000-100,000Percentages: >99%Section 3: Hazards IdentificationClassification:Not classified as hazardous according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).Potential Health Effects:Inhalation: May cause irritation of respiratory tract. Skin Contact: May cause mild irritation.Eye Contact: May cause eye irritation.Ingestion: Ingestion may cause gastrointestinalirritation or discomfort.Section 4: First Aid MeasuresInhalation: Move to fresh air. If symptoms persist, seek medical attention.Skin Contact: Remove contaminated clothing. Wash affected area with soap and water. If irritation persists, seek medical attention.Eye Contact: Rinse eyes thoroughly with water for at least15 minutes. If irritation persists, seek medical attention. Ingestion: Rinse mouth. Do not induce vomiting. Seek medical attention.Section 5: Fire Fighting MeasuresFlammability:Polydimethylsiloxane is not flammable.Extinguishing Media:Use extinguishing media appropriate for surrounding fire. Fire Fighting Instructions:Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.Section 6: Accidental Release MeasuresSpill Cleanup:Contain spillage and prevent further leakage if possible. Absorb with inert material (e.g. sand, vermiculite). Scoop up and place in a suitable container for disposal.Section 7: Handling and StorageHandling:Avoid inhalation of vapors or mist. Avoid skin contact. Wear appropriate protective clothing and equipment.Storage:Store in a cool, dry, well-ventilated area away from directsunlight and sources of heat.Section 8: Exposure Controls/Personal ProtectionEngineering Controls:Provide adequate ventilation to maintain exposure levels below recommended limits.Personal Protective Equipment:Respiratory Protection: Not normally required.Hand Protection: Wear gloves when handling.Eye Protection: Wear safety glasses or goggles.Skin Protection: Wear appropriate protective clothing as needed.Section 9: Physical and Chemical PropertiesAppearance: Clear, colorless liquidOdor: OdorlessBoiling Point: >200°CMelting Point: <-50°CFlash Point: >300°CSolubility in Water: InsolubleSection 10: Stability and ReactivityStability:Polydimethylsiloxane is stable under normal conditions of use and storage.Reactivity:Polydimethylsiloxane does not react with most chemicals. Section 11: Toxicological InformationAcute Toxicity:LD50 (Oral, Rat): >5000 mg/kgSkin Irritation:Mild irritantEye Irritation:Mild irritantSection 12: Ecological InformationEnvironmental Fate:Polydimethylsiloxane is not expected to persist in the environment.Section 13: Disposal ConsiderationsDisposal Method:Dispose in accordance with all applicable local,state/provincial, and federal regulations.Section 14: Transportation InformationNot classified as hazardous for transportation.Section 15: Regulatory InformationRegulatory Status:Polydimethylsiloxane is listed on the TSCA inventory.Section 16: Other InformationThis MSDS conforms to OSHA Hazard Communication Standard 29 CFR 1910.1200. The information contained herein is based on the present state of our knowledge and is believed to be accurate. However, no warranty, express or implied, is made with respect to such information and we assume no liability resulting from its use.。

迈瑞铁蛋白检测试剂盒说明书

Manual ProcedureAutomated procedure on requestTest PrincipleFerric ions (Fe +3) are released from transferring under acidicconditions and reduced to ferrous state (Fe +2) by a strong reducing agent. Ferrous ions then react with Ferrozine to form a coloredcomplex which can be measured photometrically. The intensity of the color produced is proportional to the iron concentration in the sample. Lipemic samples are clarified by the detergent.Transferrin-Fe-complex apotransferrin + Fe 3+Fe 3+ Fe 2+Ferrozine + Fe 2+ colored complexStability and preparation of working reagentBuffer Reagent B-R1: liquid Powder Reagent P-R1: powder. Reagent R2: liquid, ready to useWorking ReagentAdd 10 ml reagent Buffer B-R1 to one vial powder reagent P-R1 andmix gently for 15 minutes before use.Stability: 2 weeks at 20 – 25 °C1 month at2 – 8 °CAll reagents are stable up to expiry date given on label when storedat 2 – 8 °CNote : All reagents should be clear solutions. Don’t use if the reagent is turbid. Specimen Collection and Handling1. Non-hemolyzed serum is the specimen of choice.2. Serum should be separated from blood clot as soon as possible.3. Heparinized plasma could only be used, other anticoagulantsshould not be used.4. Serum iron is reported to be stable for 4 days at 20 – 25°C and7 days at 2 – 8 °C.CalibratorMediCal U Cat. No. 15011Iron STD. Cat. No. 16131Quality controlMeditrol N Cat. No. 15171 Meditrol P Cat. No. 15181Iron (Ferrozine)Colorimetric testPowder liquid reagentsCalculationConc.Iron = ⨯ Conc. Standardμμ g /dlLinearity Up to 1000 μg/dl (179 μmol/L); If result exceeds 1000 μg/dl, repeat test using diluted sample (1+1) with sodium chloride solution (0.9 %) and multiply result by 2.Interference 1. Certain drugs and other substances are known to influencecirculating iron levels. 2. To make tubes, pipettes, etc. iron free, they must be washed with diluted (1+2) hydrochloric or nitric acid followed by several rinsings with iron free deionized or distilled water.Precautions 1. The reagent is toxi c, don’t pipette by mouth, avoid all contacts. 2. Use only disposable plastic containers or iron free tubes andcuvettes. Avoid any contamination by the use of clean laboratory material.Cat. No. 12881 B-R1 1 Buffer 50mlFor 50 testsP-R1 5 powder for 10 mlR2 1 x 10 ml(A S -A SB ) SampleA standardGuanidinium PH=4.5 Ascorbic acidIron ferrozine methodReference rangeReferences1. Garoc A., Clin. Chem. Acta 94, 115 (1979).2. Brivio et coll., La Ricerca Clin. Lab. 18, 523 (1986).3. Young, DS., Effects of Drugs on Clinical Laboratory Tests, fifthedition 2000, AACC Press, Washington, D.C.。

康派特医用胶临床应用

特别提示：喷胶时创面暂时干燥、用胶量少而薄。
腔镜应用
手术创面使用生理盐水冲洗后，明显出血点给予电凝止血，将盛有医用胶的喷瓶与腔镜下用的长喷头紧密连接，从5mm的穿刺套管口送入腹腔，对准创面或出血部位，距离创面约3cm，按压喷瓶喷洒出胶液成均匀状覆盖在创面表面，几秒钟后即固化成膜，立即止血。
颅内动脉瘤和颈内动脉破裂止血：
肝脏切除术
粘合肝脏损伤创面创面止血防漏，减少胆漏发生
0-5级分级：1级反应
无致敏反应 •刺激指数（PII）：0 .8 视野内可见以中性白细胞浸润为主的炎性反应，有较多的胶原纤维和成熟的纤维细胞，无异常反应阴性
合格
合格合格
植入
合格
遗传毒性
合格
1
2
3
产品介绍
临床应用
注意事项
创面血液、组织液中阴离子作用下，快速聚合、固化成膜。胶膜与创面镶嵌紧密，由直径２－３ μ m的纤维缠绕，呈网状结构，胶膜与创面紧密镶嵌。牢固地保持伤口的对合状态，其强度可达７Ｎ（牛顿) 网状结构可阻止血球、血小板通过，，封闭创面断裂之小血管网达到有效止血胶膜将组织和细菌隔离，具抗感染和护创作用在表面形成胶膜，在脏器之间形成物理隔断，起到防止粘连作用，胶膜2-3月降解吸收
颅骨修补术：
翻开皮瓣后，将准备好的有机玻璃边缘涂胶后直接放在颅骨缺损处，与周围的软组织粘合，必要时将边缘用7号丝线与软组织缝合，固定3点，效果满意。
颅前凹低修补术：
取一块大小适当的颞骨，涂胶后置于颅底骨缺损处，然后再用涂胶的颞肌粘堵在四周围，严密封闭。
颅脑损伤手术：
外伤性颅骨粉碎性骨折：进行颅骨修补术，将碎骨块用胶粘合固定或与皮瓣粘合在一起缝合，这样粘合的颅骨瓣比较牢固，当遇到硬脑膜破损不易缝合时，取颞肌筋膜与硬脑膜粘合在一起进行修补，或间断缝合帽状腱膜后，皮瓣下涂胶，将其粘合于颅骨上。再缝合头皮，同样能防止

200种化学品理化特性表(83页)

200种化学品目录丙烯酸丁酯的理化及危险特性表 (1)丙烯酸的理化及危险特性表 (2)硝酸锌的理化及危险特性表 (3)过氧化二苯甲酰的理化及危险特性表 (4)过硫酸铵的理化及危险特性表 (5)丁酮的理化及危险特性表 (6)苯酚的主要理化和危险特性 (7)甲基叔丁基醚的主要理化及危险特性 (8)三聚氰酸的主要理化和危险特性 (9)季戊四醇的主要理化和危险特性 (10)硬脂醇的主要理化和危险特性 (11)多聚甲醛的主要理化和危险特性 (12)1，2-二甲苯的主要理化及危险特性 (13)1，3-二甲苯的主要理化及危险特性 (14)1，4-二甲苯的主要理化及危险特性 (15)环己烯的主要理化和危险特性 (16)二丁胺的主要理化和危险特性 (17)三乙胺的主要理化和危险特性 (18)甲基二氯硅烷的主要理化和危险特性 (19)异丁烯的主要理化和危险特性 (20)邻叔丁基苯酚的主要理化和危险特性 (21)对叔丁基苯酚的主要理化和危险特性 (22)环己烷的主要理化和危险特性 (23)二氯甲烷的主要理化和危险特性 (24)三氯甲烷的主要理化及危险特性 (25)硫脲的主要理化和危险特性 (26)六亚甲基四胺的主要理化和危险特性 (27)抗氧剂AT-10的主要理化和危险特性 (28)抗氧剂AT-76的主要理化和危险特性 (29)抗氧剂AT-3114的主要理化和危险特性 (30)催化剂JH-CMMS的主要理化和危险特性 (31)抗氧剂AT-168的主要理化和危险特性 (32)甲氧基钠的主要理化和危险特性 (33)氧气的理化及危险特性 (34)硝酸钾的理化及危险特性表 (35)硝酸钙的理化及危险特性表 (36)液氯的理化及危险特性 (37)盐酸的理化及危险特性 (38)丙酮理化及危险特性表 (39)次氯酸钠的理化及危险特性表 (40)二甲氧基甲烷的理化及危险特性表 (41)乙酸的理化及危险特性表 (42)香蕉水的理化及危险特性表 (43)甲醇的理化及危险特性表 (44)氰化亚铜的理化及危险特性 (45)硝酸的理化及危险特性 (46)硫酸的理化及危险特性 (47)铬酸的理化及危险特性 (48)铬酸酐的理化及危险特性 (49)氰化钠的理化及危险特性 (50)丁醇的理化及危险特性 (51)异丙醇的的理化及危险特性 (52)硝酸银的理化及危险特性表 (53)间戊二烯的理化及危险特性 (54)环戊二烯的理化及危险特性 (55)甲苯二异氰酸酯的理化及危险特性表 (56)200#溶剂油的理化及危险特性表 (57)聚氨酯漆固化剂理化及危险特性表 (58)聚氨酯漆稀释剂理化及危险特性表 (59)N，N--二甲基甲酰胺理化及危险特性 (60)丙烯腈理化及危险特性 (61)二氧化硫的特性 (62)异戊二烯的理化及危险特性 (63)醋酸丁酯的理化及危险特性 (64)醋酸乙酯的理化及危险特性 (65)甲苯的理化及危险特性 (66)环己酮的理化及危险特性 (67)三氯化铝(无水)的理化及危险特性 (68)氢氧化钠的理化及危险特性 (69)硝酸铅的理化及危险特性表 (70)电石理化及危险特性表 (71)乙炔理化及危险特性表 (72)氰化亚铜的理化及危险特性 (73)丙烯酸甲酯理化及危险特性................ 错误！未定义书签。

CHEMLOK 8110 商品安全数据表说明书

USA SAFETY DATA SHEET3000000013401. CHEMICAL PRODUCT AND COMPANY IDENTIFICATIONProduct name: CHEMLOK 8110 Product Use/Class:Aqueous AdhesiveLORD Corporation 111 LORD DriveCary, NC 27511-7923 USATelephone: 814 868-3180Non-Transportation Emergency: 814 763-2345 Chemtrec 24 Hr Transportation Emergency No.800 424-9300 (Outside Continental U.S. 703 527-3887)EFFECTIVE DATE: 08/21/20192. HAZARDS IDENTIFICATIONGHS CLASSIFICATION:Skin sensitization Category 1Reproductive toxicity Category 1BSpecific target organ systemic toxicity (single exposure) Category 1 Respiratory system, Systemic toxicity Specific target organ systemic toxicity (repeated exposure) Category 1 Aspiration hazard Category 1Hazardous to the aquatic environment - acute hazard Category 2 Hazardous to the aquatic environment - chronic hazard Category 2GHS LABEL ELEMENTS: Symbol(s)Signal WordD ANGERHazard StatementsMay cause an allergic skin reaction.May damage fertility or the unborn child.Causes damage to organs.(Respiratory system, Systemic toxicity) Causes damage to organs through prolonged or repeated exposure. May be fatal if swallowed and enters airways. Toxic to aquatic life.Toxic to aquatic life with long lasting effects.Precautionary Statements PreventionObtain special instructions before use.Do not handle until all safety precautions have been read and understood. Wear protective gloves.Use personal protective equipment as required. Do not breathe dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling.Do not eat, drink or smoke when using this product.Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment.ResponseGet medical advice/attention if you feel unwell.IF exposed: Call a POISON CENTER or doctor/physician.Specific treatment (see supplemental first aid instructions on this label).IF ON SKIN: Wash with plenty of soap and water.If skin irritation or rash occurs: Get medical advice/attention.IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.Do NOT induce vomiting.Wash contaminated clothing before reuse.Collect spillage.StorageStore locked up.Disposal:Dispose of contents/container in accordance with waste/disposal laws and regulations of your country or particular locality.Other Hazards:This product contains component(s) which have the following warnings; however based on the GHS classification criteria of your country or locale, the product mixture may be outside the respective category(s).Acute: Vapor harmful; may affect the brain or nervous system causing dizziness, headache or nausea. May cause central nervous system depression characterized by the following progressive steps: headache, dizziness, staggering gait, confusion, unconsciousness or coma. Possible irritation of the respiratory system can occur causing a variety of symptoms such as dryness of the throat, tightness of the chest, and shortness of breath. May cause skin and eyeirritation. May be harmful if swallowed. Ingestion is not an expected route of entry in industrial or commercial uses.Chronic: Prolonged or repeated contact may result in dermatitis. Repeated or prolonged solvent overexposure may result in permanent central nervous system damage. Formaldehyde may be released from this product in processes that involve heat. Formaldehyde is a skin and respiratory sensitizer, eye and throat irritant, and acute toxicant.Formaldehyde has been identified by NTP and IARC as a known human carcinogen (IARC 1), and by OSHA as a potential human carcinogen. Workplace exposure to formaldehyde is regulated by OSHA Standard 29 CFR1910.1048. IARC has designated carbon black as Group 2B - inadequate evidence for carcinogenicity in humans, but sufficient evidence in experimental animals. In 2006 IARC reaffirmed its 1995 finding that there is "inadequateevidence" from human health studies to assess whether carbon black causes cancer in humans. Further,epidemiological evidence from well-conducted investigations has shown no causative link between carbon black exposure and the risk of malignant or non-malignant respiratory disease in humans. IARC has designated titanium dioxide (TiO2) as Group 2B – possibly carcinogenic to humans in dust form. However, a number of long termanimal studies and human epidemiology studies evaluating TiO2 and workplace exposure show insufficient evidence for carcinogenic effects. EPA, NTP and OSHA do not designate TiO2 as a carcinogen and ACGIH designates TiO2 as A4 - not classifiable as a human carcinogen. Mortaility from other chronic diseases, including other respiratory diseases, was not associated with exposure to TiO2 dust. TiO2 is not present in this product as a dust and no airborne exposure is expected during application.3. COMPOSITION/INFORMATION ON INGREDIENTSChemical Name CAS Number RangeZinc compound PROPRIETARY 5 - 10%Carbon black1333-86-4 1 - 5%Propylene glycol monomethylether107-98-2 1 - 5%Nonylphenol ethoxylate compound PROPRIETARY0.1 - 0.9%Titanium dioxide13463-67-70.1 - 0.9%Resorcinol108-46-30.1 - 0.9%Any "PROPRIETARY" component(s) in the above table is considered trade secret, thus the specific chemical and its exact concentration is being withheld.The above Nonylphenol ethoxylate compound is listed by ECHA as an SVHC.4. FIRST AID MEASURESFIRST AID - EYE CONTACT: Flush eyes immediately with large amount of water for at least 15 minutes holding eyelids open while flushing. Get prompt medical attention.FIRST AID - SKIN CONTACT: Flush contaminated skin with large amounts of water while removing contaminated clothing. Wash affected skin areas with soap and water. Get medical attention if symptoms occur.FIRST AID - INHALATION: Move person to fresh air. Restore and support continued breathing. If breathing is difficult, give oxygen. Get immediate medical attention.FIRST AID - INGESTION: If swallowed, do not induce vomiting. Call a physician or poison control center immediately for further instructions. Never give anything by mouth if victim is rapidly losing consciousness, unconscious or convulsing.5. FIRE-FIGHTING MEASURESSUITABLE EXTINGUISHING MEDIA: Carbon Dioxide, Dry Chemical, Foam, Water FogUNSUITABLE EXTINGUISHING MEDIA: Not determined for this product.SPECIFIC HAZARDS POSSIBLY ARISING FROM THE CHEMICAL: Keep containers tightly closed. Closed containers may rupture when exposed to extreme heat. Use water spray to keep fire exposed containers cool. During a fire, irritating and/or toxic gases and particulate may be generated by thermal decomposition or combustion.SPECIAL PROTECTIVE EQUIPMENT AND PRECAUTIONS FOR FIRE-FIGHTERS: Wear full firefighting protective clothing, including self-contained breathing apparatus (SCBA). If water is used, fog nozzles are preferable.6. ACCIDENTAL RELEASE MEASURESPERSONAL PRECAUTIONS, PROTECTIVE EQUIPMENT AND EMERGENCY PROCEDURES: Avoid contact. Avoid breathing vapors. Use appropriate respiratory protection for large spills or spills in confined area.ENVIRONMENTAL PRECAUTIONS: Do not contaminate bodies of water, waterways, or ditches, with chemical or used container.METHODS AND MATERIALS FOR CONTAINMENT AND CLEANUP: Keep non-essential personnel a safe distance away from the spill area. Notify appropriate authorities if necessary. Avoid contact. Before attempting cleanup, refer to hazard caution information in other sections of the SDS form. Contain and remove with inert absorbent material.7. HANDLING AND STORAGEHANDLING: Keep closure tight and container upright to prevent leakage. Avoid skin and eye contact. Wash thoroughly after handling. Do not handle until all safety precautions have been read and understood. Empty containers should not be re-used. Use with adequate ventilation.STORAGE: Store only in well-ventilated areas. Keep from freezing. Keep container closed when not in use.INCOMPATIBILITY: Strong acids, bases, and strong oxidizers.8. EXPOSURE CONTROLS/PERSONAL PROTECTIONCOMPONENT EXPOSURE LIMITChemical Name ACGIH TLV-TWA ACGIH TLV-STELOSHA PEL-TWAOSHA PEL-CEILINGSkinZinc compound 2 mg/m310 mg/m3 5 mg/m3 N.E.N.A.Carbon black 3 mg/m3N.E. 3.5 mg/m3 N.E.N.A. Propylene glycolmonomethylether100 ppm150 ppm N.E. N.E.N.A.Nonylphenol ethoxylatecompoundN.E.N.E.N.E. N.E.N.A.Titanium dioxide10 mg/m3N.E.15 mg/m3 N.E.N.A.Resorcinol10 ppm20 ppm N.E. N.E.N.A.N.A. - Not Applicable, N.E. - Not Established, S - Skin DesignationEngineering controls: Sufficient ventilation in pattern and volume should be provided in order to maintain air contaminant levels below recommended exposure limits.PERSONAL PROTECTION MEASURES/EQUIPMENT:RESPIRATORY PROTECTION: Use a NIOSH approved chemical/mechanical filter respirator designed toremove a combination of particulates and organic vapor if occupational limits are exceeded. For emergencysituations, confined space use, or other conditions where exposure limits may be greatly exceeded, use an approved air-supplied respirator. For respirator use observe OSHA regulations (29CFR 1910.134) or use in accordance with applicable laws and regulations of your country or particular locality. Note: If the exposure limit for formaldehyde is exceeded, a formaldehyde-specific, formaldehyde/organic vapor combination, or airline respirator may be required.SKIN PROTECTION: Use neoprene, nitrile, or rubber gloves to prevent skin contact.EYE PROTECTION: Use safety eyewear including safety glasses with side shields and chemical goggles where splashing may occur.OTHER PROTECTIVE EQUIPMENT: Remove and wash contaminated clothing before reuse.HYGIENIC PRACTICES: Wash hands before eating, smoking, or using toilet facility. Do not smoke in anychemical handling or storage area. Food or beverages should not be consumed anywhere this product is handled or stored. Wash thoroughly after handling.9. PHYSICAL AND CHEMICAL PROPERTIESTypical values, not to be used for specification purposes.ODOR: Mild VAPOR PRESSURE: N.D.APPEARANCE: Gray VAPOR DENSITY: Heavier than Air PHYSICAL STATE: Liquid LOWER EXPLOSIVE LIMIT: 1.6 %(V)FLASH POINT:≥ 201 °F, 93 °CUPPER EXPLOSIVE LIMIT: 13.8 %(V)Setaflash Closed CupBOILING RANGE: 100 - 120 °C EVAPORATION RATE: Slower than n-butyl-acetate AUTOIGNITION TEMPERATURE:N.D.DENSITY: 1.16 g/cm3 - 9.67 lb/gal DECOMPOSITION TEMPERATURE:N.D. VISCOSITY, DYNAMIC: ≥20 mPa.s @ 25 °C ODOR THRESHOLD: N.D.VISCOSITY, KINEMATIC: ≥17 mm2/s @ 25 °CSOLUBILITY IN H2O: Water Dispersible VOLATILE BY WEIGHT: 64.55 %pH: 6.5VOLATILE BY VOLUME: 75.28 %FREEZE POINT: 32 F VOC CALCULATED: 1.23 lb/gal, 148 g/l COEFFICIENT OF WATER/OILN.D. METHOD 24: 1.70 lb/gallonDISTRIBUTION:LEGEND: N.A. - Not Applicable, N.E. - Not Established, N.D. - Not Determined10. STABILITY AND REACTIVITYHAZARDOUS POLYMERIZATION: Hazardous polymerization will not occur under normal conditions. STABILITY: Product is stable under normal storage conditions.CONDITIONS TO AVOID: High temperatures. Sources of ignition.INCOMPATIBILITY: Strong acids, bases, and strong oxidizers.HAZARDOUS DECOMPOSITION PRODUCTS: May contain CO, CO2, oxides of nitrogen, oxides of sulfur, halogenated by-products, Metal oxides11. TOXICOLOGICAL INFORMATIONEXPOSURE PATH: Refer to section 2 of this SDS.SYMPTOMS:Refer to section 2 of this SDS.TOXICITY MEASURES:Chemical Name LD50/LC50Zinc compound Oral LD50: Rat> 5,000 mg/kgGHS LC50 (vapour): Acute toxicity point estimate55 mg/l Carbon black Oral LD50: Rat> 15,400 mg/kgDermal LD50: Rabbit> 3 g/kgGHS LC50 (vapour): Acute toxicity point estimate55 mg/l Propylene glycol monomethylether Oral LD50: Rat5,000 mg/kgDermal LD50: Rabbit13 g/kgGHS LC50 (vapour): Acute toxicity point estimate11 mg/l GHS LC50(dust and mist): Acute toxicity point estimate1.5 mg/l Inhalation LC50:Rat>7559 ppm/6 hNonylphenol ethoxylate compound N.D.Titanium dioxide Oral LD50: Rat> 10,000 mg/kgDermal LD50: rabbit> 5,000 mg/kgGHS LC50 (vapour): Acute toxicity point estimate55 mg/l Resorcinol Oral LD50: Rat202 mg/kgDermal LD50: Rabbit3,360 mg/kgInhalation LC50: Rat21.3 mg/l/1 hGerm cell mutagenicity: No classification proposedCarcinogenicity: No classification proposedReproductive toxicity: Category 1B - May damage fertility or the unborn child.Components contributing to classification: Methanol.12. ECOLOGICAL INFORMATIONECOTOXICITY:Chemical Name EcotoxicityZinc compound N.D.Carbon black N.D.Propylene glycol monomethylether Fish: Pimephales promelas20.8 g/l96 h StaticInvertebrates: Daphnia magna23,300 mg/l48 hNonylphenol ethoxylate compound N.D.Titanium dioxide N.D.Resorcinol Fish: Pimephales promelas36 - 100 mg/l96 h StaticPimephales promelas100 mg/l96 h flow-throughOncorhynchus mykiss> 100 mg/l96 h flow-throughPimephales promelas53.4 mg/l96 hInvertebrates: Daphnia magna78 mg/l48 hPERSISTENCE AND DEGRADABILITY:Not determined for this product. BIOACCUMULATIVE: Not determined for this product.MOBILITY IN SOIL: Not determined for this product.OTHER ADVERSE EFFECTS: Not determined for this product.13. DISPOSAL CONSIDERATIONSDISPOSAL METHOD: Disposal should be done in accordance with Federal (40CFR Part 261), state and local environmental control regulations. If waste is determined to be hazardous, use licensed hazardous waste transporter and disposal facility.14. TRANSPORT INFORMATIONUS DOT RoadProper Shipping Name: Environmentally hazardous substances, liquid, n.o.s.Hazard Class: 9SECONDARY HAZARD: NoneUN/NA Number: 3082Packing Group: IIIEmergency Response Guide Number: 171For US DOT non-bulk road shipments this material may be classified as NOT REGULATED. For the mostaccurate shipping information, refer to your transportation/compliance department regarding changes inpackage size, mode of shipment or other regulatory descriptors.IATA CargoPROPER SHIPPING NAME: Environmentally hazardous substance, liquid, n.o.s.Hazard Class: 9HAZARD CLASS: NoneUN NUMBER: 3082PACKING GROUP: IIIEMS: 9LIMDGPROPER SHIPPING NAME: Environmentally hazardous substance, liquid, n.o.s.Hazard Class: 9HAZARD CLASS: NoneUN NUMBER: 3082PACKING GROUP: IIIEMS: F-AThe listed transportation classification applies to non-bulk shipments. It does not address regulatory variations due to changes in package size, mode of shipment or other regulatory descriptors. For the most accurate shipping information, refer to your transportation/compliance department.15. REGULATORY INFORMATIONU.S. FEDERAL REGULATIONS: AS FOLLOWS:SARA SECTION 313This product contains the following substances subject to the reporting requirements of Section 313 of Title III of the Superfund Amendment and Reauthorization Act of 1986 and 40 CFR part 372.:Chemical Name CAS Number Weight % Less ThanZinc compound PROPRIETARY10.0%TOXIC SUBSTANCES CONTROL ACT:INVENTORY STATUSThe chemical substances in this product are on the TSCA Section 8 Inventory.EXPORT NOTIFICATIONThis product contains the following chemical substances subject to the reporting requirements of TSCA 12(B) if exported from the United States:None16. OTHER INFORMATIONUnder HazCom 2012 it is optional to continue using the HMIS rating system. It is important to ensure employees have been trained to recognize the different numeric ratings associated with the HazCom 2012 and HMIS schemes.HMIS RATINGS - HEALTH: 2* FLAMMABILITY: 1 PHYSICAL HAZARD: 0* - Indicates a chronic hazard; see Section 2Revision: Section 2, Section 11Effective Date: 08/21/2019DISCLAIMERThe information contained herein is, to the best of our knowledge and belief, accurate. However, since the conditions of handling and use are beyond our control, we make no guarantee of results, and assume no liability for damages incurred by use of this material. It is the responsibility of the user to comply with all applicable federal, state and local laws and regulations.。

CFDA SE (细胞增殖示踪荧光探针) 说明书

CFDA SE (细胞增殖示踪荧光探针) 产品编号产品名称包装C1031 CFDA SE (细胞增殖示踪荧光探针) 5mg产品简介：CFDA SE 的全称为Carboxyfluorescein diacetate, succinimidyl ester ，是一种近年来被广泛应用的细胞增殖检测用荧光探针，也可以用于细胞的荧光示踪。

基于CFDA SE 荧光标记的细胞增殖检测和[3H]-thymidine 掺入、BrdU 标记获得的检测结果完全一致，但同时可以提供更多的细胞增殖信息。

使用CFDA SE 检测可以提供整个细胞群中有多少比例的细胞分裂了1次、2次或更多次数，同时如果和其它荧光探针联用，可以获取不同分裂次数细胞的其它相关信息。

CFDA-SE 的分子式为C 29H 19NO 11，分子量为557.47，CAS number 为150347-59-4。

CFDA SE 可以通透细胞膜，进入细胞后可以被细胞内的酯酶(esterase)催化分解成CFSE ，CFSE 可以偶发性地(spontaneously)并不可逆地和细胞内蛋白的Lysine 残基或其它氨基发生结合反应，并标记这些蛋白。

在加入荧光探针CFDA SE 后大约24小时，即可充分标记细胞。

被CFDA SE 标记的非分裂细胞的荧光非常稳定，稳定标记的时间可达数个月。

CFDA SE 标记细胞的荧光非常均一，比以前使用的其它细胞示踪荧光探针例如PKH26的荧光更加均一，并且分裂后的子代细胞的荧光分配也更均匀。

由于CFDA SE 标记细胞的荧光非常均匀和稳定，每分裂一次子代细胞的荧光会减弱一半，这样通过流式细胞仪检测就可以检测出没有分裂的细胞，分裂一次的细胞(1/2的荧光强度)，分离两次的细胞(1/4的荧光强度)，分裂三次的细胞(1/8的荧光强度)以及类似的其它分裂次数的细胞。

采用CFDA SE 通过流式细胞仪检测获得的检测结果参考右图。

每一个峰代表一种分裂次数的细胞，从右至左的峰通常依次为分裂0次、1次、2次、3次等次数的细胞。

Amtech Tacky 助焊膏系列安全数据表说明书

Inventec Performance Chemicals USA, LLCSAFETY DATA SHEET (SDS)SECTION 1: PRODUCT AND COMPANY IDENTIFICATIONPRODUCT NAME: Amtech Tacky Paste Flux Series: 200, 400, 500, 600, 4000, SynTECH, WSFC-305L and #61 SYNONYMS:Tacky FluxMANUFACTURER: Inventec Performance Chemicals USA, LLCADDRESS:PO Box 989 Deep River, CT 06417 USAPHONE:860-526-8300FAX:860-526-8243EMERGENCY:Infotrac-(800)535-5035REVISION DATE:December 19, 2014REVISION DATE: 3DOCUMENT NAME:SDS-Tacky Flux-008PRODUCT USE:Bonding solder joints in production and repair of circuit boardsSECTION 2: HAZARDS IDENTIFICATIONCHEMICAL NAME:N/ACHEMICAL FAMILY:MixtureCHEMICAL FORMULA:N/AROUTES OF ENTRY: Inhalation, Ingestion, Skin/Eye ContactGHS:Signal Word: WarningHazard statement(s)H302 Harmful if swallowedH317 May cause an allergic skin reactionH320 Causes eye irritationH335 May cause respiratory irritationPrecautionary statement(s)P102 Keep out of reach of childrenP233 Keep container tightly closedP264 Wash hands thoroughly after handlingP270 Do not eat, drink or smoke when using this productP280 Wear protective gloves/protective clothing/eye protection/face protectionP302+P352 IF ON SKIN: Wash with plenty of soap and waterP305+P351 IF IN EYES: Rinse continuously with water for several minutesP404 Store in a closed containerP501 Dispose of contents/containers in accordance with Federal, State/Provincial, and/or local regulations POTENTIAL HEALTH EFFECTS:EYE CONTACT: May cause moderate irritation. Do not allow material to come in contact with eyes.SKIN CONTACT: May cause moderate skin irritation.INHALATION: May cause irritation to the respiratory tract.INGESTION: Harmful if swallowed. May cause irritation to the mouth, throat, and stomach. May cause abdominal discomfort, nausea, vomiting, and/or diarrhea.CHRONIC: Not established.SECTION 2 NOTES:Inventec Performance Chemicals USA, LLC does not recommend, manufacture, market, or endorse any of its products for human consumption.SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTSIngredient CAS Number Exposure LimitsModified Rosins N/A N/APine Oil Derivatives 8000-41-7 N/AProprietary Ingredients N/A N/AMixed Carboxylic Acids N/A N/ASECTION 3 NOTES:Percentages of individual components are not listed as this information is considered a trade secret.SECTION 4: FIRST AID MEASURESEYES: Flush with plenty of water, contact a physician. If contact lenses can be removed easily, flush eyes without contact lenses. SKIN: Wash affected area with plenty of warm, soapy water. If irritation persists, seek medical attention.INGESTION: Call a physician or Poison Control Center immediately. Do not induce vomiting.INHALATION: Remove to fresh air. If not breathing, seek immediate medical attention.SECTION 5: FIRE-FIGHTING MEASURESEXTINGUISHING MEDIA: Dry chemical, foamSPECIAL FIRE FIGHTING PROCEDURES: Do not use water. Use NIOSH-approved self-contained Breathing Apparatusand full protective clothing if involved in a fire.UNUSUAL FIRE AND EXPLOSION HAZARDS:This product does not present any unusual fire and explosion hazards. SECTION 6: ACCIDENTAL RELEASE MEASURESACCIDENTAL RELEASE MEASURES: If material spills or leaks, collect and place into a properly labeled waste container. Remove traces of tacky flux using cloth rags or paper towels moistened with Isopropyl Alcohol. Follow on-site personal protective equipment recommendations.SECTION 6 NOTES:See Sections 2, 4, and 7 for additional information.SECTION 7: HANDLING AND STORAGEHANDLING/STORAGE: Keep containers tightly closed when not in use. Use care to avoid spills. Avoid inhalation of fumes or dust. Avoid contact with eyes, skin, and clothing.OTHER PRECAUTIONS: Empty containers may retain product residues in vapor, liquid, and/or solid form. All labeled hazard precautions should be observed.WORK HYGIENIC PRACTICES: Cosmetics/Food/Drink/Tobacco should not be consumed or used in work areas. Always wash hands after handling material and before applying or using cosmetics/food/drink/tobacco.SECTION 7 NOTES:For industrial use only.SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTIONVENTILATION: Provide sufficient mechanical (general and/or local exhaust) ventilation to maintain exposure below TLVs. RESPIRATORY PROTECTION: Use with adequate ventilation.EYE PROTECTION: Use with appropriate safety glasses.SKIN PROTECTION: Protective gloves and clothing should be worn when handling material. Wash hands thoroughly with soap and water upon leaving the work area.SECTION 9: PHYSICAL AND CHEMICAL PROPERTIESAPPEARANCE: Clear, White, or Yellow to Dark Amber gelODOR: Mild odorODOR THRESHOLD: Not establishedpH as SUPPLIED: N/ASECTION 9: PHYSICAL AND CHEMICAL PROPERTIES (continued)MELTING POINT: Not establishedFREEZING POINT: Not establishedINITIAL BOILING POINT: Not establishedBOILING RANGE: Not establishedFLASH POINT: Not establishedEVAPORATION RATE: Not establishedFLAMMABILITY (solid): Not establishedUPPER/LOWER FLAMMABILITY: Not establishedUPPER/LOWER EXPLOSIVE LIMITS:Not establishedVAPOR PRESSURE (mmHg): N/A (°F/°C)VAPOR DENSITY (AIR = 1): N/A (°F/°C)RELATIVE DENSITY: Not establishedSOLUBILITY IN WATER: PartiallyPARTITION COEFFICIENT (n-octanol/water): Not establishedAUTOIGNITION TEMPERATURE: Not establishedDECOMPOSITION TEMPERATURE: Not establishedVISCOSITY: N/A (°F/°C)SECTION 10: STABILITY AND REACTIVITYSTABILITY: StableCONDITIONS TO AVOID (STABILITY): Freezing temperatures. High temperatures. INCOMPATIBILITY (MATERIAL TO AVOID): Strong oxidizing materialsHAZARDOUS DECOMPOSITION/BY-PRODUCTS: Harmful organic fumes and toxic oxide fumes may form at elevatedtemperatures.POSSIBILITY OF HAZARDOUS REACTIONS: Will not occurSECTION 11: TOXICOLOGICAL INFORMATIONACUTE TOXICITY: Not availableSKIN CORRISION/IRRITATION: Not establishedSERIOUS EYE DAMAGE/IRRITATION: Not availableRESPIRATORY OR SKIN SENSITIZATION: Not establishedGERM CELL MUTAGENICITY: Not availableCARCINOGENICITY: Not availableREPRODUCTIVE TOXICITY: Not availableSTOT-SINGLE EXPOSURE: Not availableSTOT-REPEATED EXPOSURE: Not availableASPIRATION HAZARD: Not availableSECTION 12: ECOLOGICAL INFORMATIONTOXICITY: Product not testedPERSISTENCE AND DEGRADIBILITY: Product not testedBIOACCUMULATIVE POTENTIAL: Product not testedMOBILITY IN SOIL: Product not testedOTHER ADVERSE EFFECTS: Product not testedSECTION 13: DISPOSAL CONSIDERATIONSWASTE DISPOSAL METHOD: Scrap and waste solder should be stored in a dry, sealed container for later disposal. Disposal must be in accordance with Federal, State/Provincial, and Local Regulations.SECTION 14: TRANSPORT INFORMATIONTransport in accordance with applicable regulations and requirements.UN Number: Not availableUN Proper Shipping Name: Not availablePackaging Group:Not applicableEnvironmental Hazards:NoneTRANSPORT HAZARD CLASSES:US DOT Hazardous Material Classification: Tacky Flux is not listed as a DOT hazardous materialWater Transportation: Tacky Flux is not listed as a hazardous materialIATA Hazardous Material Classification: Tacky Flux is not listed as IATA hazardous materialSECTION 15: REGULATORY INFORMATIONAll ingredients used to manufacture this product are listed on the EPA TSCA Inventory.U.S. FEDERAL REGULATIONS: Not regulatedSTATE REGULATIONS: Not regulatedINTERNATIONAL REGULATIONS: Not regulatedSECTION 16: OTHER INFORMATIONHMIS Rating: Health=1 Flammability=1 Physical Hazard=0 Personal Protection=X KEY:N/A: Not applicableGHS: Global Harmonized SystemOSHA: Occupational Safety and Health AdministrationACGIH: American Conference of Governmental Industrial HygienistsNTP: National Toxicology ProgramIARC: International Agency for Research on CancerCAS: Chemical Abstract ServiceNIOSH: National Institute for Occupational Safety & HealthSTOT: Specific target organ toxicityTLV: Threshold limit valueUS DOT: United States Department of TransportationDOT: Department of TransportationIATA: International Air Transport AssociationEPA:Environmental Protection AgencyTSCA:Toxic Substance Control ActHMIS:Hazardous Material Identification SystemPREPARATION INFORMATION:This update supersedes all previously released documents.PREPARED BY: Wendy W. GesickAPPROVED BY: Leigh W. GesickDISCLAIMER:The information contained herein is based on data considered to be accurate but does not purport to be all-inclusive and shall be used only as a guide. No warranty is expressed or implied regarding the accuracy of this data and Inventec Performance Chemicals USA, LLC shall not be held liable for any damage resulting from any handling or contact with the above product. Liability is expressly disclaimed for loss or injury arising out of use of this information or the use of any materials designated. This material is not for resale, unauthorized distribution, or personal use.。

JNJ-39758979-SDS-MedChemExpress

Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Mar.-13-2018Print Date:Mar.-13-20181. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :JNJ-39758979Catalog No. :HY-101189CAS No. :1046447-90-81.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:NoneFormula:C11H19N5Molecular Weight:221.30CAS No. :1046447-90-84. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature: 4°C, protect from lightMSDStheunstable Shipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

Phanta超高保真酶

引物设计注意事项
1.引物3’端最后一个碱基选择C或G； 2.引物3’端最后8个碱基应避免出现连续错配； 3.引物3’端尽量避免出现发夹结构； 4.引物Tm值控制在55℃-65℃之间； 5.引物额外附加序列，即与模板非配对序列，不应参与引物Tm值计算； 6.引物GC含量控制在40%-60%之间； 7.正向引物和反向引物Tm值以及GC含量尽可能一致。
应用实例
1.反应体系配制：
所有操作请在冰上进行，各组分解冻后请充分摇匀。为了防止PhantaTM Super-Fidelity DNA Polymerase的校对活性降解引物，请将聚合酶最后加入反应体系中。各组分使用完毕后及时放回-20℃。5 × SF Buffer请勿长时间敞口放置。
ddH2O 5 × SF Buffer (with 10 mM MgSO4) 25 mM MgSO4a dNTP Mix (10 mM each)b
a. 对于大多数PCR反应，Mg2+最佳终浓度为1.5-2 mM。体系中已含有终浓度为2 mM Mg2+，如有需要，可用25 mM MgSO4，以0.2-0.5 mM为间隔向上摸索Mg2+最佳使用浓度。
b. 请勿使用dUTP和带有尿嘧啶的引物或模板。 c. 扩增子GC含量>60%时加入终浓度3%的DMSO有可能会有助于扩增。 d. 推荐仅当扩增子GC含量>60%且优化条件也无法正常扩增时使用；可能会降低保真度。 e. 不同模板最佳反应浓度有所不同，下表为50 μl反应体系推荐模板使用量：
DMSOc
5 × PCR Enhancerd
模板DNAe
引物1 (10 μM)
引物2 (10 μM)
PhantaTM Super-Fidelity DNA Polymerase (1 U/μl)f

安捷伦产品目录

15
Real-Time PCR
16
Mx3000P QPCR System
17
Brilliant III Ultra-Fast SYBR Green QPCR and QRT-PCR Reagents
18
Brilliant III Ultra-Fast QPCR and QRT-PCR Reagents
Agilent / STRATAGENE
Agilent website: /genomics
Welgene | Agilent Stratagene
威健股份有限公司 | Stratagene 總代理
Table of Content
Table of Contents
/ XL1-Red Competent Cells SoloPack Gold Supercompetent Cells
/ TK Competent Cells Specialty Cells
/ Classic Cells / Fine Chemicals For Competent Cells
適用於 UNG 去汙染或 bisulphite
sequencing
適用於 TA Cloning
最高敏感性
取代傳統 Taq 的好選擇
-
2
威健股份有限公司 | Stratagene 總代理
PCR Enzyme & Instrument
Agilent SureCycler 8800
市場上領先的 cycling 速度和 sample 體積 10 ～ 100 μL 簡易快速可以選擇 96 well 和 384 well 操作盤優秀的溫控設備讓各個 well 都能保持溫度的穩定七吋的高解析度觸控螢幕讓操作上更為簡便可以透過網路遠端操控儀器及監控儀器 Agilent 專業的技術支援可以幫助您應對各種 PCR 的問題

乙二醇单甲醚

乙二醇单甲醚1 基本信息中文名称：2-甲氧基乙醇、乙二醇单甲醚、乙二醇一甲醚、甲基溶纤剂、甲氧基乙醇、羟乙基甲醚英文名称：2-Methoxyethanol别名名称：Ethylene glycol Ethylene glycol monomethyl ether Methyl cellosolve Methoxyethanol分子式：C3H8O2分子量：76.09CAS号：109-86-4MDL号：MFCD00002867EINECS号：203-713-7RTECS号：KL5775000BRN号：1731074PubChem号：248571582 物性数据性状：无色透明液体沸点（ºC）：124.5熔点（ºC）：-85.1相对密度（g/mL,20/4ºC）：0.9663相对密度（g/mL,25/4ºC）：0.953230相对蒸汽密度（g/mL,空气=1）：2.62折射率（n20ºC）：1.4028折射率（n25ºC）：1.4013黏度（mPa·s,20ºC）：1.72黏度（mPa·s,25ºC）：1.60闪点（ºC,闭口）：43闪点（ºC,开口）：461燃点（ºC）：288蒸发热（KJ/mol,b.p.）：39.48燃烧热（KJ/mol）：1844.7比热容（KJ/(kg·K),25ºC,定压）：2.20电导率（S/m,20ºC）：1.09×10-6蒸气压（kPa,25ºC）：1.3蒸气压（kPa,27ºC）：1.3蒸气压（kPa,56ºC）：6.7油水（辛醇/水）分配系数的对数值：-0.503爆炸下限（%,V/V,125ºC）：2.5爆炸上限（%,V/V,140ºC）：19.8体膨胀系数（K-1,20ºC）：0.00095溶解性：与水、乙醇、乙醚、乙二醇、丙酮和DMF混溶。

KPT-330_CRM1抑制剂_Apexbio

客户使用Apexbio产品发表的文献COA (Certificate Of Analysis)MSDS (Material Safety Data Sheet)SDF(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazideC1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F分子量储存条件一般建议为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。

储液可以在零下20℃中保存数月。

运输条件试用装：蓝冰运输。

其他可选规格：常温运输或根据您的要求用蓝冰运输。

产品描述KPT-330是KPT-185的类似物,是一种CRM1的选择性抑制剂[1].染色体维持蛋白1(CRM1)是一种核外运受体,参与转录因子\细胞周期调控子\癌症抑制子和RNA分子的主动转运.在癌症中,CRM1过表达并过度转运[1].KPT-330是一种口服生物可利用的CRM1选择性抑制剂.在肾癌(RCC)细胞中,KPT-330可抑制CRM1,并可增加p21的核定位.另外,KPT-330可诱发细胞凋亡并抑制细胞生长[2].在人类非小细胞肺癌(NSCLC)细胞中,KPT-330可抑制细胞增殖,诱发细胞凋亡相关蛋白的表达和细胞周期停滞[3].在MiaPaCa-2异种移植小鼠模型中,KPT-330(20 mg/kg)可显著抑制肿瘤生长而不具有显著毒性或导致体重下降.另外,KPT-330可增加PAR-4\促凋亡Bax\剪切PARP和caspase-3.这些结果表明KPT-330通过活化PAR-4信号途径诱发细胞凋亡[1].在人NSCLC异种移植小鼠中,KPT-330可显著抑制肿瘤生长[3].参考文献：[1]. Azmi AS, Aboukameel A, Bao B, et al. Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice. Gastroenterology, 2013, 144(2): 447-456.[2]. Wettersten HI, Landesman Y, Friedlander S, et al. Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth. PLoS One, 2014, 9(12): e113867.[3]. Sun H, Hattori N, Chien W, et al. KPT-330 has antitumour activity against non-small cell lung cancer. Br J Cancer, 2014, 111(2): 281-291.。

E1005 液体样本总胆固醇酶法测定试剂盒说明书

液体样本总胆固醇酶法测定试剂盒E1005描述：血浆总胆固醇包括2/3的胆固醇酯和1/3的游离胆固醇，是血脂的重要组分，二者与心脑血管疾病以及多种病理状态密切相关。

本试剂盒采用世界卫生组织(WHO)、美国FDA、中国《全国临床检验操作规程》推荐的总胆固醇和游离胆固醇检测方法，灵敏度高，检测范围20~5000 µmol/L。

可靠性和重复性俱佳。

原理：本试剂盒测定方法采用CHOD-PAP终点方法结合经典GPO Trinder酶学反应【1】【2】,其原理为：(1) 胆固醇酯酶分解胆固醇酯为游离胆固醇。

(2) 胆固醇氧化酶将游离胆固醇氧化，产生过氧化氢。

(3) 在过氧化物酶催化下生色底物转化为苯醌亚胺，光密度值与胆固醇浓度成正比。

参考文献1.Trinder, P. (1969). Annals of Clin. Biochem. 6: 24 – 272.Barham D and Trinder P. (1972). Analyst 97: 142 – 145测定样品范围：血清、培养基组成：(1) R1试剂40 ml (2) R2试剂10 ml (3) 5 mmol/L胆固醇标准品0.5 ml储存条件：4ºC保存，6个月有效所需设备：721、722型可见光分光光度计、酶标仪、生化分析仪。

最佳工作波长550-555nm，如仪器无此波长建议优先选用570 nm，次选530、490nm。

常规比色杯即可。

操作步骤：一、工作溶液配制: 按4:1比例，取4 ml R1试剂与1 ml R2试剂混合均匀，立即使用或4ºC保存<1天，变色弃去。

二、样本处理：培养基：取无酚红无血清细胞培养液，4ºC，10,000g离心5 min，取上清测定。

新鲜培养基4ºC存放不宜超过1小时，若暂时无法测定可70ºC加热10 min后冻存，测定前离心。

血液：新鲜血液4ºC，2000 g离心5 min得到血浆，非抗凝血4ºC放置2小时得到血清。

Etomoxir_DataSheet_MedChemExpress

Inhibitors, Agonists, Screening Libraries Data SheetBIOLOGICAL ACTIVITY:Etomoxir is a potent inhibitor of carnitine palmitoyltransferase–I (CPT–1).IC50 & Target: CPT–1[1]In Vitro: Etomoxir binds irreversibly to the catalytic site of CPT–1 inhibiting its activity, but also upregulates fatty acid oxidation enzymes. Etomoxir is developed as an inhibitor of the mitochondrial carnitine palmitoyltransferase–1 (CPT–1) located on the outer mitochondrial membrane. Etomoxir, in the liver can act as peroxisomal proliferator, increasing DNA synthesis and liver growth.Thus, etomoxir, in addition of being a CPT1 inhibitor could be considered as a PPARalpha agonist [1]. Etomoxir is a member of the oxirane carboxylic acid carnitine palmitoyl transferase I inhibitors and has been suggested as a therapeutic agent for the treatment of heart failure. Acute Etomoxir treatment irreversibly inhibits the activity of carnitine palmitoyltransferase I. As a result, fatty acid import into the mitochondria and β–oxidation is reduced, whereas cytosolic fatty acid accumulates and glucose oxidation is elevated. Prolonged incubation (24 h) with Etomoxir produces diverse effects on the expression of several metabolic enzyme [2].In Vivo: Etomoxir is an inhibitor of free fatty acid (FFA) oxidation–related key enzyme CPT1. P53 interacts directly with Bax, which is inhibited by Etomoxir, further confirming the direct interaction of P53 and Bax, and the involvement of FAO–mediatedmitochondrial ROS generation in db/db mice [3]. Rats are injected daily with Etomoxir, a specific CPT–I inhibitor, for 8 days at 20mg/kg of body mass. Etomoxir–treated rats display a 44% reduced cardiac CPT–I activity. The treatment of Lewis rats for 8 days with 20 mg/kg Etomoxir does not alter blood glucose, which is in line with comparable etomoxir–feeding studies. Similarly, Etomoxir feeding does not affect general growth characteristics such as gain in body mass, nor does it affect hindlimb muscle mass.However, heart mass and liver mass are both significantly increased by 11% in Etomoxir–treated rats [4].PROTOCOL (Extracted from published papers and Only for reference)Cell Assay: Etomoxir is dissolved in DMSO and stored, and then diluted with appropriate medium before use [2]. [2]Rat heart H9c2 myoblastic cells are incubated in DMEM containing 10% fetal bovine serum until near confluence. In some experiments,cells are preincubated for 2 h with DMEM (serum–free) in the absence or presence of 1–80 μM Etomoxir and then incubated for 2 h with 0.1 mM [1–14C]oleic acid (10 μCi/dish, binds to BSA in a 1:1 molar ratio). In other experiments, cells arepreincubated for 2 h plus or minus 40 μM Etomoxir and then incubated for 2 h with 0.1 μM or 0.1 mM [1,3–3H]glycerol (10μCi/dish), 0.1 mM [1–14C]oleic acid (2 μCi/dish, binds to BSA in a 1:1 molar ratio), 0.1 mM [1–14C]palmitic acid (2μCi/dish, binds to BSA in a 1:1 molar ratio), 28 μM [3H]ethanolamine (2 μCi/dish), 28 μM [methyl–3H]choline (2 μCi/dish), 0.4mM [3H]serine (20 μCi/dish), or 40 μM myo–[3H]inositol (10 μCi/dish). The medium is removed and the cells washed twice withice–cold saline and then harvested from the dish with 2 mL methanol–water (1:1, v/v) for lipid extraction. An aliquot of thehomogenate is taken for the determination of total uptake of radioactivity into cells. Phospholipids are then isolated andradioactivity in these determined [2].Animal Administration: Etomoxir is dissolved in 0.9% (w/v) NaCl (Rat)[4].[3][4]Mice [3]Product Name:Etomoxir Cat. No.:HY-50202CAS No.:124083-20-1Molecular Formula:C 17H 23ClO 4Molecular Weight:326.82Target:Others Pathway:Others Solubility:10 mM in DMSO80 male C57BLKS/J lar–Lepr db/db mice and 20 wild type littermates (8 week) are used. db/db mice are randomly divided into four groups: db/db group, Etomoxir group, MitoQ group, and PFT–α group. In the Etomoxir group, mice are intraperitoneally injected with 1 mg/kg Etomoxir twice every week. In the MitoQ group, 50 μM MitoQ is given to the mice in water. Water bottles, containing either MitoQ, are covered with aluminum foil, and all bottles are refilled every 3 days. In the PFT–α group, mice are intraperitoneally injected with 1 mg/kg PFT–α twice every week. WT mice are administrated with vehicle instead. The experimental period is 8 weeks. At the end, peripheral blood samples and bone marrow cells are harvested for the assays.Rat[4]Male Lewis rats, weighing 150–200 g, are used in the present study. Animals are kept on a 12 h:12 h light/dark cycle and fed a Purina Chow diet and water ad libitum. The rats are divided into two groups: (1) control and (2) Etomoxir. Etomoxir (20 mg/kg of body weight) is dissolved in 0.9% (w/v) NaCl and administered intraperitoneally for 8 days. Control rats receive saline. The last injection is given 24 h before the experiment. Animals are anaesthetized with an intraperitoneal injection of a nembutal and heparin (3:1) mixture. Subsequently, the heart is removed for LCFA uptake studies and for analyses of transporter protein contents.References:[1]. Rupp H, et al. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz. 2002 Nov;27(7):621–36.[2]. Xu FY, et al. Etomoxir mediates differential metabolic channeling of fatty acid and glycerol precursors into cardiolipin in H9c2 cells. J Lipid Res. 2003 Feb; 44(2):415–23.[3]. Li J, et al. FFA–ROS–P53–mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus. Sci Rep. 2015 Jul 31;5:12724.[4]. Luiken JJ, et al. Etomoxir–induced partial carnitine palmitoyltransferase–I (CPT–I) inhibition in vivo does not alter cardiac long–chain fatty acid uptake and oxidation rates. Biochem J. 2009 Apr 15;419(2):447–55.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

三丁基氯化锡MSDS英文版

SIGMA-ALDRICH Material Safety Data SheetVersion 4.1Revision Date 07/28/2010Print Date 03/10/20111. PRODUCT AND COMPANY IDENTIFICATIONProduct name : TBTCProduct Number : 45713FlukaBrand :Sigma-AldrichCompany :3050 Spruce StreetSAINT LOUIS MO 63103USA+18003255832Telephone :+18003255052Fax :Emergency Phone # : (314) 776-65552. HAZARDS IDENTIFICATIONEmergency OverviewOSHA HazardsTarget Organ Effect, Toxic by ingestion, Harmful by skin absorption., IrritantTarget OrgansBlood, Liver, KidneyGHS Label elements, including precautionary statementsPictogramSignal word DangerHazard statement(s)H301 Toxic if swallowed.H312 Harmful in contact with skin.H315 Causes skin irritation.H318 Causes serious eye damage.H372 Causes damage to organs through prolonged or repeated exposure.H410 Very toxic to aquatic life with long lasting effects.Precautionary statement(s)P273 Avoid release to the environment.P280 Wear protective gloves/ eye protection/ face protection.P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician.P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, ifpresent and easy to do. Continue rinsing.P314 Get medical advice/ attention if you feel unwell.P501 Dispose of contents/ container to an approved waste disposal plant.HMIS ClassificationHealth hazard:2Chronic Health Hazard:*Flammability:1Physical hazards:0NFPA RatingHealth hazard:2Fire:1Reactivity Hazard:0Potential Health EffectsInhalation May be harmful if inhaled. Causes respiratory tract irritation.Skin Causes skin irritation.Eyes Causes eye irritation.Ingestion Toxic if swallowed.3. COMPOSITION/INFORMATION ON INGREDIENTSchlorideTributyltinSynonyms :TBTCTributylchlorotinC12H27ClSnFormula :Molecular Weight : 325.51 g/molCAS-No. EC-No.Index-No. ConcentrationTributyltin chloride- 1461-22-9 215-958-7050-008-00-34. FIRST AID MEASURESGeneral adviceConsult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area.If inhaledIf breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.In case of skin contactWash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.In case of eye contactRinse thoroughly with plenty of water for at least 15 minutes and consult a physician.If swallowedNever give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.5. FIRE-FIGHTING MEASURESSuitable extinguishing mediaUse water spray, alcohol-resistant foam, dry chemical or carbon dioxide.Special protective equipment for fire-fightersWear self contained breathing apparatus for fire fighting if necessary.6. ACCIDENTAL RELEASE MEASURESPersonal precautionsWear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Environmental precautionsPrevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.Methods and materials for containment and cleaning upSoak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed containers for disposal.7. HANDLING AND STORAGEPrecautions for safe handlingAvoid contact with skin and eyes. Avoid inhalation of vapour or mist.Normal measures for preventive fire protection.Conditions for safe storageKeep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage.Recommended storage temperature: 2 - 8 °C8. EXPOSURE CONTROLS/PERSONAL PROTECTIONComponents with workplace control parametersComponents CAS-No. Value ControlparametersUpdate BasisTributyltin chloride 1461-22-9 TWA0.1 mg/m3 1997-08-04 USA. Occupational Exposure Limits(OSHA) - Table Z-1 Limits for AirContaminantsTWA0.1 mg/m3 2007-01-01 USA. ACGIH Threshold Limit Values(TLV)Remarks Not classifiable as a human carcinogen: Agents which cause concern that they could becarcinogenic for humans but which cannot be assessed conclusively because of a lack of data. Invitro or animal studies do not provide indications of carcinogenicity which are sufficient to classifythe agent into one of the other categories. Danger of cutaneous absorption variesSTEL0.2 mg/m3 2007-01-01 USA. ACGIH Threshold Limit Values(TLV)Not classifiable as a human carcinogen: Agents which cause concern that they could becarcinogenic for humans but which cannot be assessed conclusively because of a lack of data. Invitro or animal studies do not provide indications of carcinogenicity which are sufficient to classifythe agent into one of the other categories. Danger of cutaneous absorption variesTWA0.1 mg/m3 1989-01-19 USA. OSHA - TABLE Z-1 Limits for AirContaminants - 1910.1000SkinnotationCorrection: CAS number [7440-31-5] has been deleted, since this is a group.Personal protective equipmentRespiratory protectionWhere risk assessment shows air-purifying respirators are appropriate use a full-face respirator with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls. If therespirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).Hand protectionHandle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use inaccordance with applicable laws and good laboratory practices. Wash and dry hands.Eye protectionTightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).Skin and body protectionComplete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.Hygiene measuresAvoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product.9. PHYSICAL AND CHEMICAL PROPERTIESAppearanceliquidForm clear,yellowColour lightSafety datapH no data availableMelting point no data availableBoiling point 171 - 173 °C (340 - 343 °F) at 33 hPa (25 mmHg) - lit.Flash point 113 °C (235 °F) - closed cupIgnition temperature no data availableLower explosion limit no data availableUpper explosion limit no data availableDensity 1.2 g/cm3 at 25 °C (77 °F)Water solubility no data available10. STABILITY AND REACTIVITYChemical stabilityStable under recommended storage conditions.Conditions to avoidno data availableMaterials to avoidStrong oxidizing agentsHazardous decomposition productsHazardous decomposition products formed under fire conditions. - Carbon oxides, Hydrogen chloride gas, Tin/tin oxides 11. TOXICOLOGICAL INFORMATIONAcute toxicityLD50Oral - rat - 129 mg/kgSkin corrosion/irritationSerious eye damage/eye irritationEyes - rabbit - Severe eye irritation - 24 hRespiratory or skin sensitizationno data availableGerm cell mutagenicityno data availableCarcinogenicityIARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as acarcinogen or potential carcinogen by ACGIH.NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP.OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as acarcinogen or potential carcinogen by OSHA.Reproductive toxicityno data availableSpecific target organ toxicity - single exposure (Globally Harmonized System)no data availableSpecific target organ toxicity - repeated exposure (Globally Harmonized System)Causes damage to organs through prolonged or repeated exposure.Aspiration hazardno data availablePotential health effectsInhalation May be harmful if inhaled. Causes respiratory tract irritation.Ingestion Toxic if swallowed.Skin Causes skin irritation.Eyes Causes eye irritation.Signs and Symptoms of ExposureTo the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.Additional InformationRTECS: WH682000012. ECOLOGICAL INFORMATIONToxicityToxicity to fish LC50 - Oncorhynchus mykiss (rainbow trout) - 0.011 - 0.015 mg/l - 96 hToxicity to daphniaEC50 - Daphnia magna (Water flea) - 0.018 mg/l - 48 hand other aquaticinvertebrates.Toxicity to algae mortality LOEC - Phyllospora comosa - 0.001 µg/l - 96 hmortality EC50 - Skeletonema costatum - 0.006 mg/l - 72 hmortality NOEC - Phyllospora comosa - < 0.001 µg/l - 96 hPersistence and degradabilityBioaccumulative potentialBioaccumulation Poecilia reticulata (guppy) - 14 dBioconcentration factor (BCF): 460Mobility in soilno data availablePBT and vPvB assessmentno data availableOther adverse effectsAn environmental hazard cannot be excluded in the event of unprofessional handling or disposal.Very toxic to aquatic life with long lasting effects.13. DISPOSAL CONSIDERATIONSProductOffer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional wastedisposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in achemical incinerator equipped with an afterburner and scrubber.Contaminated packagingDispose of as unused product.14. TRANSPORT INFORMATIONDOT (US)UN-Number:2788 Class: 6.1 Packing group: IIIMarine pollutant: NoPoison Inhalation Hazard: NoIMDGUN-Number: 2788 Class: 6.1 Packing group: III EMS-No: F-A, S-AProper shipping name: ORGANOTIN COMPOUND, LIQUID, N.O.S. (Tributyltin chloride)Marine pollutant: Marine pollutantIATAUN-Number:2788 Class: 6.1 Packing group: IIIProper shipping name: Organotin compound, liquid, n.o.s. (Tributyltin chloride)15. REGULATORY INFORMATIONOSHA HazardsTarget Organ Effect, Toxic by ingestion, Harmful by skin absorption., IrritantDSL StatusAll components of this product are on the Canadian DSL list.SARA 302 ComponentsSARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 ComponentsSARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312HazardsAcute Health Hazard, Chronic Health HazardMassachusetts Right To Know ComponentsNo components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know ComponentsTributyltin chloride CAS-No.1461-22-9Revision DateNew Jersey Right To Know ComponentsTributyltin chloride CAS-No.1461-22-9Revision DateCalifornia Prop. 65 ComponentsThis product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other reproductive harm.16. OTHER INFORMATIONFurther informationCopyright 2010 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only.The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.。

化学品英文名称

批注本地保存成功开通会员云端永久保存去开通
Filling material A AC 45 UBI / FR 310 5000 Acetic acid (5% at 20°C) Acetic acid (5% at 50°C) Acetic acid (at 40°C) Acetic acid (at 50°C) Acetic acid anhydride Acetoacetate, ethylAcetoacetate, methylAcetone Acetulan Acetyl chloride Acricid 40 EC Acricid liquid Acryl amide Acrylat 38092, solvent base Acrylic acid Acrylic Polymere RDZ 1263 Acrylic Polymere RDZ 2738 Acrylic Polymere RDZ 2771 Acrylic Polymere RDZ 958 Acrylic Polymere RZ 20810 Acrylic Polymere RZ 21376 Acrylic Polymere RZ 421 Activated carbon Activoll EFL Addipast 350 WD black Additol XK 391 Additol XK 406 Adhesion Promoter AMS 70 After Shave Afugan Aircraft fuel Aircraft fuel, Jet A1 Akypo RO 90 VG Akypo RO 90 VG Aldehyde C12 Aldehyde C8 Aldurol VUP 21 Aldurol VUP 51 Alkydal R 35 W Allylic heptylate